TLX
Price:
$10.1
Market Cap:
$4.77B
Telix Pharmaceuticals Limited, a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic and diagnostic radiopharmaceuticals. The company operates through three segments: Precision Medicine, Therapeutics, and Manufacturing Solutions. Its lead therapeutic product candidate is TLX591, a lutetium-labeled radio antibody-drug conjugate (rADC), which is in a Phase 3 clinical trial in patients with advanced prostate cancer. The company develops TLX250, an rADC for treating advanced metastatic kidney cancer; TLX101, a systemic therapy for the treatment of glioblastoma; TLX66, a product candidate for bone marrow conditioning for hematopoietic stem c...[Read more]
Industry
Biotechnology
IPO Date
2024-11-14
Stock Exchange
NASDAQ
Ticker
TLX
According to Telix Pharmaceuticals Limited’s latest financial reports and current stock price. The company's current PE Ratio is -548.91. This represents a change of 306.37% compared to the average of -135.08 of the last 4 quarters.
The mean historical PE Ratio of Telix Pharmaceuticals Limited over the last ten years is -223.19. The current -548.91 PE Ratio has changed 24.49% with respect to the historical average. Over the past ten years (40 quarters), TLX's PE Ratio was at its highest in in the June 2024 quarter at 129.58. The PE Ratio was at its lowest in in the June 2025 quarter at -592.72.
Average
-223.19
Median
-17.15
Minimum
-2566.67
Maximum
618.40
Discovering the peaks and valleys of Telix Pharmaceuticals Limited PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 433.33%
Maximum Annual PE Ratio = 618.40
Minimum Annual Increase = -2992.13%
Minimum Annual PE Ratio = -2566.67
| Year | PE Ratio | Change |
|---|---|---|
| 2025 | -342.51 | -308.76% |
| 2024 | 164.07 | -73.47% |
| 2023 | 618.40 | -2992.13% |
| 2022 | -21.38 | -19.99% |
| 2021 | -26.72 | 20.19% |
| 2020 | -22.24 | 72.14% |
| 2019 | -12.92 | 35.92% |
| 2018 | -9.50 | -23.67% |
| 2017 | -12.45 | -99.51% |
| 2016 | -2566.67 | 433.33% |
The current PE Ratio of Telix Pharmaceuticals Limited (TLX) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
146.65
5-year avg
78.37
10-year avg
-223.19
Telix Pharmaceuticals Limited’s PE Ratio is less than Mirum Pharmaceuticals, Inc. (-7.90), less than Soleno Therapeutics, Inc. (27.09), less than Dyne Therapeutics, Inc. (-7.54), less than ADMA Biologics, Inc. (12.62), less than Belite Bio, Inc (-59.78), less than Ligand Pharmaceuticals Incorporated (36.74), less than ACADIA Pharmaceuticals Inc. (11.81), less than Ultragenyx Pharmaceutical Inc. (-4.09), less than Celcuity Inc. (-21.40), less than Praxis Precision Medicines, Inc. (-21.73),
| Company | PE Ratio | Market cap |
|---|---|---|
| -7.90 | $6.56B | |
| 27.09 | $2.76B | |
| -7.54 | $4.61B | |
| 12.62 | $2.02B | |
| -59.78 | $6.11B | |
| 36.74 | $5.77B | |
| 11.81 | $4.51B | |
| -4.09 | $2.46B | |
| -21.40 | $4.06B | |
| -21.73 | $8.11B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Telix Pharmaceuticals Limited using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Telix Pharmaceuticals Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Telix Pharmaceuticals Limited's PE Ratio?
How is the PE Ratio calculated for Telix Pharmaceuticals Limited (TLX)?
What is the highest PE Ratio for Telix Pharmaceuticals Limited (TLX)?
What is the 3-year average PE Ratio for Telix Pharmaceuticals Limited (TLX)?
What is the 5-year average PE Ratio for Telix Pharmaceuticals Limited (TLX)?
How does the current PE Ratio for Telix Pharmaceuticals Limited (TLX) compare to its historical average?